|
NUF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66344715779587E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.056100000009E-05 |
| Normal-vs-Stage2 |
1.536040E-02 |
| Normal-vs-Stage3 |
1.85983999999584E-05 |
| Normal-vs-Stage4 |
4.036200E-02 |
| Stage1-vs-Stage2 |
4.883400E-01 |
| Stage1-vs-Stage3 |
8.234900E-04 |
| Stage1-vs-Stage4 |
8.163900E-02 |
| Stage2-vs-Stage3 |
1.136190E-02 |
| Stage2-vs-Stage4 |
1.143610E-01 |
| Stage3-vs-Stage4 |
4.892000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.63009971976669E-10 |
| Normal-vs-AfricanAmerican |
1.211140E-04 |
| Normal-vs-Asian |
3.712400E-02 |
| Caucasian-vs-AfricanAmerican |
3.879000E-01 |
| Caucasian-vs-Asian |
1.827800E-01 |
| AfricanAmerican-vs-Asian |
3.108300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.05440142464886E-11 |
| Normal-vs-Female |
2.071299999995E-05 |
| Male-vs-Female |
4.212400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.203000E-03 |
| Normal-vs-Extreme_Weight |
6.34190000514678E-08 |
| Normal-vs-Obese |
1.70820000000571E-06 |
| Normal-vs-Extreme_Obese |
2.354200E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.237380E-01 |
| Normal_Weight-vs-Obese |
6.746000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.713900E-02 |
| Extreme_Weight-vs-Obese |
5.091600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.769600E-02 |
| Obese-vs-Extreme_Obese |
2.018300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.244900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.5724000041194E-08 |
| Normal-vs-Age(61-80Yrs) |
2.13129999999673E-05 |
| Normal-vs-Age(81-100Yrs) |
1.725990E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.373500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.455200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.853880E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.485200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.081500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.612800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.31339947198705E-10 |
| Normal-VS-Type2 PRCC |
1.847720E-04 |
| Normal-VS-KIRP CIMP |
2.020800E-04 |
| Normal-VS-Unclassified PRCC |
5.446600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.602400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.436700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.442030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.438800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.325600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.135370E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68379999999835E-05 |
| Normal-vs-N1 |
2.27359999999122E-05 |
| Normal-vs-N2 |
1.080220E-01 |
| N0-vs-N1 |
4.007900E-04 |
| N0-vs-N2 |
4.316200E-02 |
| N1-vs-N2 |
3.589000E-01 |
|
|
